1. Home
  2. AYTU

as of 02-11-2026 4:00pm EST

$2.27
$0.04
-1.73%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Founded: N/A Country:
United States
United States
Employees: N/A City: DENVER
Market Cap: 25.7M IPO Year: N/A
Target Price: $9.33 AVG Volume (30 days): 88.9K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.02 EPS Growth: N/A
52 Week Low/High: $0.95 - $3.06 Next Earning Date: 02-03-2026
Revenue: $62,640,000 Revenue Growth: 2.00%
Revenue Growth (this year): -15.09% Revenue Growth (next year): 47.32%
P/E Ratio: N/A Index: N/A
Free Cash Flow: -698000.0 FCF Growth: N/A

AI-Powered AYTU Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 74.84%
74.84%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Aytu BioPharma Inc. News

AYTU Breaking Stock News: Dive into AYTU Ticker-Specific Updates for Smart Investing

All AYTU News

Share on Social Networks: